Lombard Odier Asset Management (USA)’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-31,819
| Closed | -$58.2K | – | 249 |
|
|
2024
Q4 | $58.2K | Buy |
+31,819
| New | +$58.2K | ﹤0.01% | 210 |
|
|
2024
Q3 | – | Sell |
-94,557
| Closed | -$130K | – | 275 |
|
|
2024
Q2 | $130K | Buy |
94,557
+20,092
| +27% | +$27.5K | 0.01% | 171 |
|
|
2024
Q1 | $279K | Buy |
+74,465
| New | +$279K | 0.01% | 182 |
|
|
2020
Q3 | – | Sell |
-407,273
| Closed | -$1.41M | – | 198 |
|
|
2020
Q2 | $1.41M | Hold |
407,273
| – | – | 0.1% | 96 |
|
|
2020
Q1 | $1.25M | Sell |
407,273
-45,253
| -10% | -$138K | 0.13% | 108 |
|
|
2019
Q4 | $2.33M | Buy |
452,526
+152,526
| +51% | +$784K | 0.21% | 89 |
|
|
2019
Q3 | $1.55M | Buy |
+300,000
| New | +$1.55M | 0.15% | 112 |
|
|
2019
Q2 | – | Sell |
-80,000
| Closed | -$578K | – | 221 |
|
|
2019
Q1 | $578K | Sell |
80,000
-40,000
| -33% | -$289K | 0.05% | 136 |
|
|
2018
Q4 | $888K | Sell |
120,000
-680,000
| -85% | -$5.03M | 0.07% | 123 |
|
|
2018
Q3 | $4.33M | Buy |
+800,000
| New | +$4.33M | 0.32% | 65 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 206 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 192 |
|
|
2016
Q4 | – | Sell |
-200,000
| Closed | -$1.79M | – | 193 |
|
|
2016
Q3 | $1.79M | Buy |
+200,000
| New | +$1.79M | 0.17% | 128 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 209 |
|